Compare Lustrum:Daito Pharmaceutical Co.,Ltd.:4577

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Daito Pharmaceutical Co.,Ltd. Go to web site 4577 Medicals 東証プライム May 1, 2000 2010.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Daito Pharmaceutical Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Daito Pharmaceutical Co.,Ltd. Balance Sheet 2024年5月期 Daito Pharmaceutical Co.,Ltd. Balance Sheet 2023年5月期 Daito Pharmaceutical Co.,Ltd. Balance Sheet 2022年5月期 Daito Pharmaceutical Co.,Ltd. Balance Sheet 2021年5月期 Daito Pharmaceutical Co.,Ltd. Balance Sheet 2020年5月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date May 31, 2024 May 31, 2023 May 31, 2022 May 31, 2021 May 31, 2020
Cash and Cash Equivalents
(Percent)
2,727down
(3.5%)down
3,607down
(5.1%)down
4,381up
(6.7%)up
3,373up
(5.8%)up
3,084
(5.7%)
Other Current AssetsHelp
(Percent)
38,733up
(49.8%)down
37,056up
(52.5%)up
33,528up
(51.6%)up
29,057up
(50.3%)down
27,771
(51.2%)
Tangible Fixed AssetsHelp
(Percent)
31,972up
(41.1%)up
25,837up
(36.6%)up
23,116up
(35.6%)down
21,372up
(37.0%)up
19,400
(35.8%)
Intangible Fixed AssetHelp
(Percent)
490up
(0.6%)up
377down
(0.5%)down
386up
(0.6%)up
333up
(0.6%)up
299
(0.6%)
Investments and OthersHelp
(Percent)
3,786up
(4.9%)down
3,675up
(5.2%)down
3,528down
(5.4%)down
3,605down
(6.2%)down
3,696
(6.8%)
Total AssetsHelp
(Percent)
77,708
(100%)
70,552
(100%)
64,939
(100%)
57,739
(100%)
54,250
(100%)
Total Current LiabilitiesHelp
(Percent)
19,294up
(24.8%)up
16,435up
(23.3%)down
15,385up
(23.7%)down
14,102down
(24.4%)down
16,158
(29.8%)
Total Long-term LiabilitiesHelp
(Percent)
6,345up
(8.2%)up
3,445up
(4.9%)up
2,247up
(3.5%)down
2,019up
(3.5%)up
1,583
(2.9%)
Shareholder's EquityHelp
(Percent)
52,069up
(67.0%)down
50,672up
(71.8%)down
47,307up
(72.8%)up
41,619up
(72.1%)up
36,509
(67.3%)
Total LiabilitiesHelp
(Percent)
77,708
(100%)
70,552
(100%)
64,939
(100%)
57,739
(100%)
54,250
(100%)

Daito Pharmaceutical Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2024年5月期 Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2023年5月期 Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2022年5月期 Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2021年5月期 Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2020年5月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date May 31, 2024 May 31, 2023 May 31, 2022 May 31, 2021 May 31, 2020
Amount of Sales
(Percent)
46,895
(100%)
45,101
(100%)
43,464
(100%)
48,715
(100%)
44,991
(100%)
Total Sales
(Percent)
46,895
(100%)
45,101
(100%)
43,464
(100%)
48,715
(100%)
44,991
(100%)
Cost of SalesHelp
(Percent)
37,056up
(79.0%)up
34,770up
(77.1%)up
32,005down
(73.6%)down
37,917up
(77.8%)down
35,513
(78.9%)
Other Costs and RevenueHelp 6,545down
(14.0%)down
6,732down
(14.9%)down
6,791up
(15.6%)up
6,551up
(13.4%)up
5,534
(12.3%)
Total CostsHelp 43,601 41,502 38,796 44,469 41,047
Net RevenueHelp 9,839down
(21.0%)down
10,331down
(22.9%)down
11,459up
(26.4%)up
10,798up
(22.2%)up
9,479
(21.1%)
Earnings Before TaxHelp 4,218down
(9.0%)down
5,076down
(11.3%)down
6,720up
(15.5%)up
5,874up
(12.1%)down
5,595
(12.4%)
Net IncomeHelp 3,294down
(7.0%)down
3,599down
(8.0%)down
4,668up
(10.7%)up
4,246up
(8.7%)down
3,945
(8.8%)
当期純利益 3,294 3,599 4,668 4,246 3,945

Daito Pharmaceutical Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2024年5月期 Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2023年5月期 Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2022年5月期 Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2021年5月期 Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2020年5月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date May 31, 2024 May 31, 2023 May 31, 2022 May 31, 2021 May 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
5,183up
(84.8%)up
4,156down
(74.7%)down
4,371down
(80.8%)up
5,183up
(78.4%)down
4,306
(100.0%)
Investing Cash Flow(ICF)Help
(Percent)
-5,930down
(-97.0%)up
-5,566down
(-100.0%)down
-4,400up
(-81.4%)up
-6,324down
(-95.6%)down
-2,681
(-62.3%)
Financing Cash FlowHelp
(Percent)
-183down
(-3.0%)down
616down
(11.1%)down
989down
(18.3%)down
1,425up
(21.5%)up
-350
(-8.1%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
51up
(0.8%)up
20down
(0.4%)down
48up
(0.9%)up
6up
(0.1%)up
-10
(-0.2%)
Net Increase and Decrease in Cash and Cash Equivalentsn -879down
(-14.4%)down
-774down
(-13.9%)down
1,008up
(18.6%)up
289down
(4.4%)down
1,265
(29.4%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Daito Pharmaceutical Co.,Ltd.

Company where related level is highHelp

GNI Group Ltd.
MUROMACHI CHEMICALS INC.
Kidswell Bio Corporation
JCR Pharmaceuticals Co.,Ltd.
KYORIN Pharmaceutical Co., Ltd.
StemRIM Inc.
Carna Biosciences,Inc.
Toyama Chemical Co.,Ltd.
CellSource Co., Ltd.
Immuno-Biological Laboratories Co., Ltd.